Clinical Invesigative Site 3116 — Sarasota, Florida

Clinical Invesigative Site 3116 is a clinical research site located in Sarasota, Florida, United States 34233.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Invesigative Site 3116 has participated in 1 clinical trials.

Therapeutic areas: Multiple Sclerosis.

Sponsors: Actelion.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Invesigative Site 3116?

Clinical Invesigative Site 3116 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Invesigative Site 3116 conducted?

Clinical Invesigative Site 3116 has 1 clinical trials on record. Their work covers Multiple Sclerosis.

Is Clinical Invesigative Site 3116 accredited by Crixeo Health?

Clinical Invesigative Site 3116 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Invesigative Site 3116?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.